<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcbioinformatics&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Bioinformatics - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcbioinformatics/</link>
        <description>The latest research articles published by BMC Bioinformatics</description>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/29" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/28" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/27" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/26" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/25" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/24" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/23" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/22" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/21" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2105/13/19" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/29">
        <title>Method: Automatic segmentation of mitochondria utilizing patch classification, contour pair classification, and automatically seeded level sets</title>
        <description>Background:
While progress has been made to develop automatic segmentation techniques for mitochondria, there remains a need for more accurate and robust techniques to delineate mitochondria in serial blockface scanning electron microscopic data.  Previously developed texture based methods are limited for solving this problem because texture alone is often not sufficient to identify mitochondria. This paper presents a new three-step method, the Cytoseg process, for automated segmentation of mitochondria contained in 3D electron microscopic volumes generated through serial block face scanning electron microscopic imaging.  The method consists of three steps. The first is a random forest patch classification step operating directly on 2D image patches. The second step consists of contour-pair classification. At the final step, we introduce a method to automatically seed a level set operation with output from previous steps.
Results:
We report accuracy of the Cytoseg process on three types of tissue and compare it to a previous method based on Radon-Like Features. At step 1, we show that the patch classifier identifies mitochondria texture but creates many false positive pixels. At step 2, our contour processing step produces contours and then filters them with a second classification step, helping to improve overall accuracy. We show that our final level set operation, which is automatically seeded with output from previous steps, helps to smooth the results. Overall, our results show that use of contour pair classification and level set operations improve segmentation accuracy beyond patch classification alone. We show that the Cytoseg process performs well compared to another modern technique based on Radon-Like Features.
Conclusions:
We demonstrated that texture based methods for mitochondria segmentation can be enhanced with multiple steps that form an image processing pipeline. While we used a random-forest based patch classifier to recognize texture, it would be possible to replace this with other texture identifiers, and we plan to explore this in future work.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/29</link>
                <dc:creator>Richard Giuly</dc:creator>
                <dc:creator>Maryann Martone</dc:creator>
                <dc:creator>Mark Ellisman</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:29</dc:source>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-29</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-29-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>29</prism:startingPage>
        <prism:publicationDate>2012-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/28">
        <title>Identification of Polymorphic Inversions from Genotypes </title>
        <description>Background:
Polymorphic inversions are a source of genetic variability with a direct impact on recombination frequencies. Given the difficulty of their experimental study, computational methods have been developed to infer their existence in a large number of individuals using genome-wide data of nucleotide variation. Methods based on haplotype tagging of known inversions attempt to classify individuals as having a normal or inverted allele.  Other methods that measure differences between linkage disequilibrium attempt to identify regions with inversions but unable to classify subjects accurately, an essential requirement for association studies.
Results:
We present a novel method to both identify polymorphic inversions from genome-wide genotype data and classify individuals as containing a normal or inverted allele. Our method, a generalization of a published method for haplotype data [1], utilizes linkage between groups of SNPs to partition a set of individuals into normal and inverted subpopulations. We employ a sliding window scan to identify regions likely to have an inversion, and accumulation of evidence from neighboring SNPs is used to accurately determine the inversion status of each subject. Further, our approach detects inversions directly from genotype data, thus increasing its usability to current genome-wide association studies (GWAS).
Conclusions:
We demonstrate the accuracy of our method to detect inversions and classify individuals on principled-simulated genotypes, produced by the evolution of an inversion event within a coalescent model [2].  We applied our method to real genotype data from HapMap Phase III to characterize the inversion status of two known inversions within the regions 17q21 and 8p23 across 1184 individuals. Finally, we scan the full genomes of the European Origin (CEU) and Yoruba (YRI) HapMap samples. We find population-based evidence for 9 out of 15 well-established autosomic inversions, and for 52 regions previously predicted by independent experimental methods in ten (9+1) individuals [3, 4]. We provide efficient implementations of both genotype and haplotype methods as a unified R package inveRsion.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/28</link>
                <dc:creator>Alejandro Caceres</dc:creator>
                <dc:creator>Suzanne Sindi</dc:creator>
                <dc:creator>Benjamin Raphael</dc:creator>
                <dc:creator>Mario Caceres</dc:creator>
                <dc:creator>Juan Gonzalez</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:28</dc:source>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-28</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-28-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>28</prism:startingPage>
        <prism:publicationDate>2012-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/27">
        <title>Model-based peak alignment of metabolomic profiling from comprehensive two-dimensional gas chromatography mass spectrometry</title>
        <description>Background:
Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry (GCxGC/TOF-MS) has been used for metabolite profiling in metabolomics. However, there is still much experimental variation to be controlled including both within-experiment and between-experiment variation. For efficient analysis, an ideal peak alignment method to deal with such variations is in great need.
Results:
Using experimental data of a mixture of metabolite standards, we demonstrated that our method has better performance than other existing method which is not model-based. We then applied our method to the data generated from the plasma of a rat, which also demonstrates good performance of our model.
Conclusions:
We developed a model-based peak alignment method to process both homogeneous and heterogeneous experimental data. The unique feature of our method is the only model-based peak alignment method coupled with metabolite identification in an unified framework. Through the comparison with other existing method, we demonstrated that our method has better performance. Data are available at http://stage.louisville.edu/faculty/x0zhan17/software/software-development/mspa. The R source codes are available at http://www.biostat.iupui.edu/~ChangyuShen/CodesPeakAlignment.zip.Trial Registration: 2136949528613691</description>
        <link>http://www.biomedcentral.com/1471-2105/13/27</link>
                <dc:creator>Jaesik Jeong</dc:creator>
                <dc:creator>Xue Shi</dc:creator>
                <dc:creator>Xiang Zhang</dc:creator>
                <dc:creator>Seongho Kim</dc:creator>
                <dc:creator>Changyu Shen</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:27</dc:source>
        <dc:date>2012-02-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-27</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-27-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>27</prism:startingPage>
        <prism:publicationDate>2012-02-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/26">
        <title>Consensus embedding: theory, algorithms and application
to segmentation and classification of biomedical data</title>
        <description>Background:
Dimensionality reduction (DR) enables the construction of a lower dimensional space (embedding) from a higher dimensional feature space while preserving object-class discriminability. However several popular DR approaches suffer from sensitivity to choice of parameters and/or presence of noise in the data. In this paper, we present a novel DR technique known as consensus embedding that aims to overcome these problems by generating and combining multiple low-dimensional embeddings, hence exploiting the variance among them in a manner similar to ensemble classifier schemes such as Bagging. We demonstrate theoretical properties of consensus embedding which show that it will result in a single stable embedding solution that preserves information more accurately as compared to any individual embedding (generated via DR schemes such as Principal Component Analysis, Graph Embedding, or Locally Linear Embedding). Intelligent sub-sampling (via mean-shift) and code parallelization are utilized to provide for an efficient implementation of the scheme.
Results:
Applications of consensus embedding are shown in the context of classification and clustering as applied to: (1) image partitioning of white matter and gray matter on 10 different synthetic brain MRI images corrupted with 18 different combinations of noise and bias field inhomogeneity, (2) classification of 4 high-dimensional gene-expression datasets, (3) cancer detection (at a pixel-level) on 16 image slices obtained from 2 different high-resolution prostate MRI datasets. In over 200 different experiments concerning classification and segmentation of biomedical data, consensus embedding was found to consistently outperform both linear and non-linear DR methods within all applications considered.
Conclusions:
We have presented a novel framework termed consensus embedding which leverages ensemble classification theory within dimensionality reduction, allowing for application to a wide range of high-dimensional biomedical data classification and segmentation problems. Our generalizable framework allows for improved representation and classification in the context of both imaging and non-imaging data. The algorithm offers a promising solution to problems that currently plague DR methods, and may allow for extension to other areas of biomedical data analysis.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/26</link>
                <dc:creator>Satish Viswanath</dc:creator>
                <dc:creator>Anant Madabhushi</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:26</dc:source>
        <dc:date>2012-02-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-26</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-26-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2012-02-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/25">
        <title>Predicting tissue specific cis-regulatory modules in the human genome using pairs of co-occurring motifs</title>
        <description>Background:
Researchers seeking to unlock the genetic basis of human physiology and diseases have been studying gene transcription regulation. The temporal and spatial patterns of gene expression are controlled by mainly non-coding elements known as cis-regulatory modules (CRMs) and epigenetic factors. CRMs modulating related genes share the regulatory signature which consists of transcription factor (TF) binding sites (TFBSs). Identifying such CRMs is a challenging problem due to the prohibitive number of sequence sets that need to be analyzed.
Results:
We formulated the challenge as a supervised classification problem even though experimentally validated CRMs were not required. Our efforts resulted in a software system named CrmMiner. The system mines for CRMs in the vicinity of related genes. CrmMiner requires two sets of sequences: a mixed set and a control set. Sequences in the vicinity of the related genes comprise the mixed set, whereas the control set includes random genomic sequences. CrmMiner assumes that a large percentage of the mixed set is made of background sequences that do not include CRMs. The system identifies pairs of closely located motifs representing vertebrate TFBSs that are enriched in the training mixed set consisting of 50% of the gene loci. In addition, CrmMiner selects a group of the enriched pairs to represent the tissue-specific regulatory signature. The mixed and the control sets are searched for candidate sequences that include any of the selected pairs. Next, an optimal Bayesian classifier is used to distinguish candidates found in the mixed set from their control counterparts. Our study proposes 62 tissue-specific regulatory signatures and putative CRMs for different human tissues and cell types. These signatures consist of assortments of ubiquitously expressed TFs and tissue-specific TFs. Under controlled settings, CrmMiner identified known CRMs in noisy sets up to 1:25 signal-to-noise ratio. CrmMiner was 21-75% more precise than a related CRM predictor. The sensitivity of the system to locate known human heart enhancers reached up to 83%. CrmMiner precision reached 82% while mining for CRMs specific to the human CD4+ T cells. On several data sets, the system achieved 99% specificity.
Conclusion:
These results suggest that CrmMiner predictions are accurate and likely to be tissue-specific CRMs. We expect that the predicted tissue-specific CRMs and the regulatory signatures broaden our knowledge of gene transcription regulation.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/25</link>
                <dc:creator>Hani Girgis</dc:creator>
                <dc:creator>Ivan Ovcharenko</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:25</dc:source>
        <dc:date>2012-02-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-25</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-25-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2012-02-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/24">
        <title>Independent Principal Component Analysis for biologically
meaningful dimension reduction of large biological data sets</title>
        <description>Background:
A key question when analyzing high throughput data is whether the information provided by themeasured biological entities (gene, metabolite expression for example) is related to the experimental conditions, or, rather, to some interfering signals, such as experimental bias or artefacts. Visualization tools are therefore useful to better understand the underlying structure of the data in a &apos;blind&apos; (unsupervised) way. A well-established technique to do so is Principal Component Analysis (PCA). PCA is particularly powerful if the biological question is related to the highest variance. Independent Component Analysis (ICA) has been proposed as an alternative to PCA as it optimizes an independence condition to give more  meaningful components. However, neither PCA nor ICA can overcome both the high dimensionality and noisy characteristics of biological data.
Results:
We propose Independent Principal Component Analysis (IPCA) that combines the advantages of bothPCA and ICA. It uses ICA as a denoising process of the loading vectors produced by PCA to better highlight theimportant biological entities and reveal insightful patterns in the data. The result is a better clustering of thebiological samples on graphical representations. In addition, a sparse version is proposed that performs aninternal variable selection to identify biologically relevant features (sIPCA).
Conclusions:
On simulation studies and real data sets, we showed that IPCA offers a better visualization of thedata than ICA and with a smaller number of components than PCA. Furthermore, a preliminary investigation of the list of genes selected with sIPCA demonstrate that the approach is well able to highlight relevant genes inthe data with respect to the biological experiment.IPCA and sIPCA are both implemented in the R package mixOmics dedicated to the analysis and exploration ofhigh dimensional biological data sets, and on mixOmics&apos; web-interface.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/24</link>
                <dc:creator>Fangzhou Yao</dc:creator>
                <dc:creator>Jeff Coquery</dc:creator>
                <dc:creator>Kim-Anh Le Cao</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:24</dc:source>
        <dc:date>2012-02-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-24</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-24-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2012-02-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/23">
        <title>Markov Chain Ontology Analysis (MCOA)</title>
        <description>Background:
Biomedical ontologies have become an increasingly critical lens through which researchers analyze the genomic, clinical and bibliographic data that fuels scientific research. Of particular relevance are methods, such as enrichment analysis, that quantify the importance of ontology classes relative to a collection of domain data. Current analytical techniques, however, remain limited in their ability to handle many important types of structural complexity encountered in real biological systems including class overlaps, continuously valued data, inter-instance relationships, non-hierarchical relationships between classes, semantic distance and sparse data.
Results:
In this paper, we describe a methodology called Markov Chain Ontology Analysis (MCOA) and illustrate its use through a MCOA-based enrichment analysis application based on a generative model of gene activation.  MCOA models the classes in an ontology, the instances from an associated dataset and all directional inter-class, class-to-instance and inter-instance relationships as a single finite ergodic Markov chain. The adjusted transition probability matrix for this Markov chain enables the calculation of eigenvector values that quantify the importance of each ontology class relative to other classes and the associated data set members.  On both controlled Gene Ontology (GO) data sets created with Escherichia coli, Drosophila melanogaster and Homo sapiens annotations and real gene expression data extracted from the Gene Expression Omnibus (GEO), the MCOA enrichment analysis approach provides the best performance of comparable state-of-the-art methods.
Conclusion:
A methodology based on Markov chain models and network analytic metrics can help detect the relevant signal within large, highly interdependent and noisy data sets and, for applications such as enrichment analysis, has been shown to generate superior performance on both real and simulated data relative to existing state-of-the-art approaches.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/23</link>
                <dc:creator>H Frost</dc:creator>
                <dc:creator>Alexa McCray</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:23</dc:source>
        <dc:date>2012-02-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-23</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-23-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2012-02-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/22">
        <title>Analysis of Energy-based Algorithms for RNA Secondary Structure Prediction</title>
        <description>Background:
RNA molecules play critical roles in the cells of organisms, including roles in gene regulation, catalysis, and synthesis of proteins. Since RNA function depends in large part on its folded structures, much effort has been invested in developing accurate methods for prediction of RNA secondary structure from the base sequence. Minimum free energy (MFE) predictions are widely used, based on nearest neighbor thermodynamic parameters of Mathews, Turner et al. or those of Andronescu et al. Some recently proposed alternatives that leverage partition function calculations find the structure with maximum expected accuracy (MEA) or pseudo-expected accuracy (pseudo-MEA) methods. Advances in prediction methods are typically benchmarked using sensitivity, positive predictive value and their harmonic mean, namely F-measure, on datasets of known reference structures. Since such benchmarks document progress in improving accuracy of computational prediction methods, it is important to understand how measures of accuracy vary as a function of the reference datasets and whether advances in algorithms or thermodynamic parameters yield statistically significant improvements. Our work advances such understanding for the MFE and (pseudo-)MEA-based methods, with respect to the latest datasets and energy parameters.
Results:
We present three main findings. First, using the bootstrap percentile method, we show that the average F-measure accuracy of the MFE and (pseudo-)MEA-based algorithms, as measured on our largest datasets with over 2000 RNAs from diverse families, is a reliable estimate (within a 2% range with high confidence) of the accuracy of a population of RNA molecules represented by this set. However, average accuracy on smaller classes of RNAs such as a class of 89 Group I introns used previously in benchmarking algorithm accuracy is not reliable enough to draw meaningful conclusions about the relative merits of the MFE and MEA-based algorithms. Second, on our large datasets, the algorithm with best overall accuracy is a pseudo MEA-based algorithm of Hamada et al. that uses a generalized centroid estimator of base pairs. However, between MFE and other MEA-based methods, there is no clear winner in the sense that the relative accuracy of the MFE versus MEA-based algorithms changes depending on the underlying energy parameters. Third, of the four parameter sets we considered, the best accuracy for the MFE-, MEA-based, and pseudo-MEA-based methods is 0.686, 0.680, and 0.711, respectively (on a scale from 0 to 1 with 1 meaning perfect structure predictions) and is obtained with a thermodynamic parameter set obtained by Andronescu et al. called BL* (named after the Boltzmann likelihood method by which the parameters were derived).
Conclusions:
Large datasets should be used to obtain reliable measures of the accuracy of RNA structure prediction algorithms, and average accuracies on specific classes (such as Group I introns and Transfer RNAs) should be interpreted with caution, considering the relatively small size of currently available datasets for such classes. The accuracy of the MEA-based methods is significantly higher when using the BL* parameter set of Andronescu et al. than when using the parameters of Mathews and Turner, and there is no significant difference between the accuracy of MEA-based methods and MFE when using the BL* parameters. The pseudo-MEA-based method of Hamada et al. with the BL* parameter set significantly outperforms all other MFE and MEA-based algorithms on our large data sets.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/22</link>
                <dc:creator>Monir Hajiaghayi</dc:creator>
                <dc:creator>Anne Condon</dc:creator>
                <dc:creator>Holger Hoos</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:22</dc:source>
        <dc:date>2012-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-22</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-22-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2012-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/21">
        <title>Fast automatic quantitative cell replication with fluorescent live cell imaging</title>
        <description>Background:
live cell imaging is a useful tool to monitor cellular activities in living systems. It is often necessary in cancer research or experimental research to quantify the dividing capabilities of cells or the cell proliferation level when investigating manipulations of the cells or their environment. Manual quantification of fluorescence microscopic image is difficult because human is neither sensitive to fine differences in color intensity nor effective to count and average fluorescence level among cells. However, auto-quantification is not a straightforward problem to solve. As the sampling location of the microscopy changes, the amount of cells in individual microscopic images varies, which makes simple measurement methods such as the sum of stain intensity values or the total number of positive stain within each image inapplicable. Thus, automated quantification with robust cell segmentation techniques is required.
Results:
An automated quantification system with robust cell segmentation technique are presented. The experimental results in application to monitor cellular replication activities show that the quantitative score is promising to represent the cell replication level, and scores for images from different cell replication groups are demonstrated to be statistically significantly different using ANOVA, LSD and Tukey HSD tests (p-value&lt;0.01). In addition, the technique is fast and takes less than 0.5 second for high resolution microscopic images (with image dimension 2560 * 1920).
Conclusion:
A robust automated quantification method of live cell imaging is built to measure the cell replication level, providing a robust quantitative analysis system in fluorescent live cell imaging. In addition, the presented unsupervised entropy based cell segmentation for live cell images is demonstrated to be also applicable for nuclear segmentation of IHC tissue images.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/21</link>
                <dc:creator>Ching-Wei Wang</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:21</dc:source>
        <dc:date>2012-01-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-21</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-21-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2012-01-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2105/13/19">
        <title>TranscriptomeBrowser 3.0 : introducing a new compendium of molecular interactions and a new visualization tool for the study of gene regulatory networks</title>
        <description>Background:
Deciphering gene regulatory networks by in silico approaches is a crucial step in the study of the molecular perturbations that occur in diseases. The development of regulatory maps is a tedious process requiring the comprehensive integration of various evidences scattered over biological databases. Thus, the research community would greatly benefit from having a unified database storing known and predicted molecular interactions. Furthermore, given the intrinsic complexity of the data, the development of new tools offering integrated and meaningful visualizations of molecular interactions is necessary to help users drawing new hypotheses without being overwhelmed by the density of the subsequent graph.
Results:
We extend the previously developed TranscriptomeBrowser database with a set of tables containing  1,594,978 human and mouse molecular interactions. The database includes: (i) predicted regulatory interactions (computed by scanning vertebrate alignments with a set of 1,213 position weight matrices), (ii) potential regulatory interactions inferred from systematic analysis of ChIP-seq experiments, (iii) regulatory interactions curated from the literature, (iv) predicted post-transcriptional regulation by micro-RNA, (v) protein kinase-substrate interactions and (vi) physical protein-protein interactions. In order to easily retrieve and efficiently analyze these interactions, we developed InteractomeBrowser, a graph-based knowledge browser that comes as a plug-in for TranscriptomeBrowser. The first objective of InteractomeBrowser is to provide a user-friendly tool to get new insight into any gene list by providing a context-specific display of putative regulatory and physical interactions. To achieve this, InteractomeBrowser relies on a &quot;cell compartments-based layout&quot; that makes use of a subset of the Gene Ontology to map gene products onto relevant cell compartments. This layout is particularly powerful for visual integration of heterogeneous biological information and is a productive avenue in generating new hypotheses. The second objective of InteractomeBrowser is to fill the gap between interaction databases and dynamic modeling. It is thus compatible with the network analysis software Cytoscape and with the Gene Interaction Network simulation software (GINsim). We provide examples underlying the benefits of this visualization tool for large gene set analysis related to thymocyte differentiation.
Conclusions:
The InteractomeBrowser plugin is a powerful tool to get quick access to a knowledge database that includes both predicted and validated molecular interactions. InteractomeBrowser is available through the TranscriptomeBrowser framework and can be found at : http://tagc.univ-mrs.fr/tbrowser/. Our database is updated on a regular basis.</description>
        <link>http://www.biomedcentral.com/1471-2105/13/19</link>
                <dc:creator>Cyrille Lepoivre</dc:creator>
                <dc:creator>Aurelie Bergon</dc:creator>
                <dc:creator>Fabrice Lopez</dc:creator>
                <dc:creator>Narayanan Perumal</dc:creator>
                <dc:creator>Catherine Nguyen</dc:creator>
                <dc:creator>Jean Imbert</dc:creator>
                <dc:creator>Denis Puthier</dc:creator>
                <dc:source>BMC Bioinformatics 2012, null:19</dc:source>
        <dc:date>2012-01-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2105-13-19</dc:identifier>
                                <prism:require>/content/figures/1471-2105-13-19-toc.gif</prism:require>
                <prism:publicationName>BMC Bioinformatics</prism:publicationName>
        <prism:issn>1471-2105</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2012-01-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

